SGLT2 Inhibitors Market Insights, Size, Share & Industry Report, 2026-2034

Table of Contents

1. Introduction
    1.1. Report Description
        1.1.1. Objectives of the Study
        1.1.2. Market Scope
        1.1.3. Assumptions
    1.2. Stakeholders
2. Executive Summary
    2.1. Market Highlights
3. Research Methodology
    3.1. Overview
        3.1.1. Data Mining
    3.2. Data Sources
        3.2.1. Primary Sources
        3.2.2. Secondary Sources
4. Global SGLT2 Inhibitors Market Insights
    4.1. SGLT2 Inhibitors Market – Distribution Channel Snapshot
    4.2. SGLT2 Inhibitors Market Dynamics
        4.2.1. Drivers and Opportunities
            4.2.1.1. The Global Rise of the Aging Population is Driving Market Growth
            4.2.1.2. Rising New Drug Approvals Drive Market Outlook
        4.2.2. Restraints and Challenges
            4.2.2.1. High Cost of Medication
    4.3. Porter’s Five Forces Analysis
        4.3.1. Bargaining Power of Suppliers (Moderate)
        4.3.2. Threats of New Entrants: (Low)
        4.3.3. Bargaining Power of Buyers (Moderate)
        4.3.4. Threat of Substitute (Moderate)
        4.3.5. Rivalry among existing firms (High)
    4.4. PESTEL Analysis
    4.5. SGLT2 Inhibitors Market Distribution Channel Trends
    4.6. Value Chain Analysis
    4.7. COVID-19 Impact Analysis
5. Global SGLT2 Inhibitors Market, by Indication
    5.1. Key Findings
    5.2. Introduction
        5.2.1. Global SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
    5.3. Cardiovascular
        5.3.1. Global SGLT2 Inhibitors Market, by Cardiovascular, by Region, 2021-2034 (USD Billion)
    5.4. Chronic Kidney Disease (CKD)
        5.4.1. Global SGLT2 Inhibitors Market, by Chronic Kidney Disease (CKD), by Region, 2021-2034 (USD Billion)
    5.5. Type 2 Diabetes
        5.5.1. Global SGLT2 Inhibitors Market, by Type 2 Diabetes, by Region, 2021-2034 (USD Billion)
    5.6. Others
        5.6.1. Global SGLT2 Inhibitors Market, by Others, by Region, 2021-2034 (USD Billion)
6. Global SGLT2 Inhibitors Market, by Drug
    6.1. Key Findings
    6.2. Introduction
        6.2.1. Global SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
    6.3. Farxiga (Dapagliflozin)
        6.3.1. Global SGLT2 Inhibitors Market, by Farxiga (Dapagliflozin), by Region, 2021-2034 (USD Billion)
    6.4. Inpefa (Sotagliflozin)
        6.4.1. Global SGLT2 Inhibitors Market, by Inpefa (Sotagliflozin), by Region, 2021-2034 (USD Billion)
    6.5.Invokana (Canagliflozin)
        6.5.1. Global SGLT2 Inhibitors Market, by Invokana (Canagliflozin), by Region, 2021-2034 (USD Billion)
6.6. Jardiance (Empagliflozin)
        6.6.1. Global SGLT2 Inhibitors Market, by Jardiance (Empagliflozin), by Region, 2021-2034 (USD Billion)
6.5. Qtern (Dapagliflozin/Saxagliptin)
        6.5.1. Global SGLT2 Inhibitors Market, by Qtern (Dapagliflozin/Saxagliptin), by Region, 2021-2034 (USD Billion)
6.5. Other SGLT2 Inhibitors
        6.5.1. Global SGLT2 Inhibitors Market, by Other SGLT2 Inhibitors, by Region, 2021-2034 (USD Billion)
7. Global SGLT2 Inhibitors Market, by Distribution Channel
    7.1. Key Findings
    7.2. Introduction
        7.2.1. Global SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
    7.3. Hospital Pharmacies
        7.3.1. Global SGLT2 Inhibitors Market, by Hospital Pharmacies, By Region, 2021-2034 (USD Billion)
    7.4. Online Pharmacies
        7.4.1. Global SGLT2 Inhibitors Market, by Online Pharmacies, By Region, 2021-2034 (USD Billion)
    7.5. Retail Pharmacies
        7.5.1. Global SGLT2 Inhibitors Market, by Retail Pharmacies, By Region, 2021-2034 (USD Billion)
8. Global SGLT2 Inhibitors Market, by Geography
    8.1. Key findings
    8.2. Introduction
        8.2.1. SGLT2 Inhibitors Market Assessment, By Geography, 2021-2034 (USD Billion)
    8.3. SGLT2 Inhibitors Market – North America
        8.3.1. North America: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
        8.3.2. North America: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.3.3. North America: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.3.4. SGLT2 Inhibitors Market – U.S.
            8.3.4.1. U.S.: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.3.4.2. U.S.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.3.4.3. U.S.: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.3.5. SGLT2 Inhibitors Market – Canada
            8.3.5.1. Canada: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.3.5.2. Canada.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.3.5.3. Canada: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
    8.4. SGLT2 Inhibitors Market – Europe
        8.4.1. Europe: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
         8.4.2. Europe.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.4.3. Europe: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.4.4. SGLT2 Inhibitors Market – UK
            8.4.4.1. UK: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.4.4.2. UK.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.4.4.3. UK: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.4.5. SGLT2 Inhibitors Market – France
            8.4.5.1. France: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.4.5.2. France.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.4.5.3. France: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.4.6. SGLT2 Inhibitors Market – Germany
            8.4.6.1. Germany: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.4.6.2. Germany.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.4.6.3. Germany: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.4.7. SGLT2 Inhibitors Market – Italy
            8.4.7.1. Italy: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.4.7.2. Italy.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.4.7.3. Italy: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.4.8. SGLT2 Inhibitors Market – Spain
            8.4.8.1. Spain: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.4.8.2. Spain.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.4.8.3. Spain: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.4.9. SGLT2 Inhibitors Market – Netherlands
            8.4.9.1. Netherlands: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.4.9.2. Netherlands.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.4.9.3. Netherlands: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.4.10. SGLT2 Inhibitors Market – Russia
            8.4.10.1. Russia: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.4.10.2. Russia.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.4.10.3. Russia: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.4.11. SGLT2 Inhibitors Market – Rest of Europe
            8.4.11.1. Rest of Europe: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.4.11.2. Rest of Europe.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.4.11.3. Rest of Europe: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
    8.5. SGLT2 Inhibitors Market – Asia Pacific
        8.5.1. Asia Pacific: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
        8.5.2. Asia Pacific.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.5.3. Asia Pacific: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.5.4. SGLT2 Inhibitors Market – China
            8.5.4.1. China: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.5.4.2. China.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.5.4.3. China: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.5.5. SGLT2 Inhibitors Market – India
            8.5.5.1. India: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.5.5.2. India.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.5.5.3. India: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.5.6. SGLT2 Inhibitors Market – Malaysia
            8.5.6.1. Malaysia: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.5.6.2. Malaysia.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.5.6.3. Malaysia: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.5.7. SGLT2 Inhibitors Market – Japan
            8.5.7.1. Japan: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.5.7.2. Japan.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.5.7.3. Japan: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.5.8. SGLT2 Inhibitors Market – Indonesia
            8.5.8.1. Indonesia: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.5.8.2. Indonesia.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.5.8.3. Indonesia: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.5.9. SGLT2 Inhibitors Market – South Korea
            8.5.9.1. South Korea: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.5.9.2. South Korea: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.5.9.3. South Korea: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.5.10. SGLT2 Inhibitors Market – Australia
            8.5.10.1. Australia: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.5.10.2. Australia: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.5.10.3. Australia: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
8.5.11. SGLT2 Inhibitors Market – Rest of Asia Pacific
            8.5.11.1. Rest of Asia Pacific: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.5.11.2. Rest of Asia Pacific: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.5.11.3. Rest of Asia Pacific: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
    8.6. SGLT2 Inhibitors Market – Middle East & Africa
        8.6.1. Middle East & Africa: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
        8.6.2. Middle East & Africa.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.6.3. Middle East & Africa: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.6.4. SGLT2 Inhibitors Market – Saudi Arabia
            8.6.4.1. Saudi Arabia: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.6.4.2. Saudi Arabia.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.6.4.3. Saudi Arabia: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.6.5. SGLT2 Inhibitors Market – UAE
            8.6.5.1. UAE: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.6.5.2. UAE.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.6.5.3. UAE: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.6.6. SGLT2 Inhibitors Market – Israel
            8.6.6.1. Israel: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.6.6.2. Israel.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.6.6.3. Israel: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.6.7. SGLT2 Inhibitors Market – South Africa
            8.6.7.1. South Africa: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.6.7.2. South Africa.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.6.7.3. South Africa: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.6.8. SGLT2 Inhibitors Market – Rest of Middle East & Africa
            8.6.8.1. Rest of Middle East & Africa: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.6.8.2. Rest of Middle East & Africa: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.6.8.3. Rest of Middle East & Africa: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
    8.7. SGLT2 Inhibitors Market – Latin America
        8.7.1. Latin America: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
        8.7.2. Latin America.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
        8.7.3. Latin America: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.7.4. SGLT2 Inhibitors Market – Mexico
            8.7.4.1. Mexico: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.7.4.2. Mexico.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.7.4.3. Mexico: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.7.5. SGLT2 Inhibitors Market – Brazil
            8.7.5.1. Brazil: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.7.5.2. Brazil.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.7.5.3. Brazil: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.7.6. SGLT2 Inhibitors Market – Argentina
            8.7.6.1. Argentina: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.7.6.2. Argentina.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.7.6.3. Argentina: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
        8.7.7. SGLT2 Inhibitors Market – Rest of Latin America
            8.7.7.1. Rest of Latin America: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
            8.7.7.2. Rest of Latin America.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
            8.7.7.3. Rest of Latin America: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
9. Competitive Landscape
    9.1. Expansion and Acquisition Analysis
        9.1.1. Expansion
        9.1.2. Acquisitions
    9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
    10.1. AstraZeneca
        10.1.1. Company Overview
        10.1.2. Financial Performance
        10.1.3. Product Benchmarking
        10.1.4. Recent Development
    10.2. Boehringer Ingelheim International GmbH
        10.2.1. Company Overview
        10.2.2. Financial Performance
        10.2.3. Product Benchmarking
        10.2.4. Recent Development
    10.3. Bristol-Myers Squibb Company
        10.3.1. Company Overview
        10.3.2. Financial Performance
        10.3.3. Product Benchmarking
        10.3.4. Recent Development
    10.4. Eli Lilly and Company
        10.4.1. Company Overview
        10.4.2. Financial Performance
        10.4.3. Product Benchmarking
        10.4.4. Recent Development
    10.5. Glenmark Pharmaceuticals Ltd.
        10.5.1. Company Overview
        10.5.2. Financial Performance
        10.5.3. Product Benchmarking
        10.5.4. Recent Development
    10.6. Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals, Inc.)
        10.6.1. Company Overview
        10.6.2. Financial Performance
        10.6.3. Product Benchmarking
        10.6.4. Recent Development
    10.7. Lexicon Pharmaceuticals, Inc.
        10.7.1. Company Overview
        10.7.2. Financial Performance
        10.7.3. Product Benchmarking
        10.7.4. Recent Development
    10.8. Merck & Co., Inc.
        10.8.1. Company Overview
        10.8.2. Financial Performance
        10.8.3. Product Benchmarking
        10.8.4. Recent Development
    10.9. Sanofi
        10.9.1. Company Overview
        10.9.2. Financial Performance
        10.9.3. Product Benchmarking
        10.9.4. Recent Development
    10.10. TheracosBio, LLC
        10.10.1. Company Overview
        10.10.2. Financial Performance
        10.10.3. Product Benchmarking
        10.10.4. Recent Development
List of Tables
Table 1 Global SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 2 Global SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 3 Global SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 4 SGLT2 Inhibitors Market Assessment, By Geography, 2021-2034 (USD Billion)
Table 5 North America: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 6 North America: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 7 North America: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 8 U.S.: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 9 U.S.: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 10 U.S.: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 11 Canada: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 12 Canada: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 13 Canada: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 14 Europe: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 15 Europe: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 16 Europe: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 17 UK: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 18 UK: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 19 UK: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 20 France: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 21 France: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 22 France: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 23 Germany: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 24 Germany: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 25 Germany: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 26 Italy: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 27 Italy: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 28 Italy: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 29 Spain: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 30 Spain: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 31 Spain: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 32 Netherlands: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 33 Netherlands: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 34 Netherlands: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 35 Russia: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 36 Russia: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 37 Russia: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 38 Rest of Europe: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 39 Rest of Europe: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 40 Rest of Europe: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 41 Asia Pacific: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 42 Asia Pacific: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 43 Asia Pacific: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 44 China: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 45 China: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 46 China: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 47 India: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 48 India: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 49 India: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 50 Malaysia: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 51 Malaysia: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 52 Malaysia: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 53 Japan: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 54 Japan: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 55 Japan: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 56 Indonesia: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 57 Indonesia: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 58 Indonesia: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 59 South Korea: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 60 South Korea: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 61 South Korea: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 62 Australia: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 63 Australia: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 64 Australia: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 65 Rest of Asia Pacific: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 66 Rest of Asia Pacific: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 67 Rest of Asia Pacific: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 68 Middle East & Africa: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 69 Middle East & Africa: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 70 Middle East & Africa: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 71 Saudi Arabia: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 72 Saudi Arabia: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 73 Saudi Arabia: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 74 UAE: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 75 UAE: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 76 UAE: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 77 Israel: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 78 Israel: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 79 Israel: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 80 South Africa: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 81 South Africa: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 82 South Africa: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 83 Rest of Middle East & Africa: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 84 Rest of Middle East & Africa: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 85 Rest of Middle East & Africa: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 86 Latin America: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 87 Latin America: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 88 Latin America: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 89 Mexico: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 90 Mexico: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 91 Mexico: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 92 Brazil: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 93 Brazil: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 94 Brazil: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 95 Argentina: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 96 Argentina: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 97 Argentina: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
Table 98 Rest of Latin America: SGLT2 Inhibitors Market, by Indication, 2021-2034 (USD Billion)
Table 99 Rest of Latin America: SGLT2 Inhibitors Market, by Drug, 2021-2034 (USD Billion)
Table 100 Rest of Latin America: SGLT2 Inhibitors Market, by Distribution Channel, 2021-2034 (USD Billion)
List of Figures
Figure 1. Global SGLT2 Inhibitors Market, 2021-2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter’s Five Forces
Figure 6. Market by Indication
Figure 7. Global SGLT2 Inhibitors Market, by Indication, 2025 & 2034 (USD Billion)
Figure 8. Market by Drug
Figure 9. Global SGLT2 Inhibitors Market, by Drug, 2025 & 2034 (USD Billion)
Figure 10. Market by Distribution Channel
Figure 11. Global SGLT2 Inhibitors Market, by Distribution Channel, 2025 & 2034 (USD Billion)